![Fabio M. Benedetti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fabio M. Benedetti
Plus aucun poste en cours
Profil
Fabio M.
Benedetti worked as a Senior Medical Director-Oncology at Bristol Myers Squibb Co. from 1999 to 2002.
He then worked as Vice President-Global Medical Affairs at Millennium Pharmaceuticals, Inc. from 2002 to 2005, followed by a role as Vice President-Medical Affairs at Onyx Pharmaceuticals, Inc. in 2005-2006.
From 2007 to 2011, he served as Chief Medical Officer-Oncology & SVP at Geron Corp.
He then worked as Global Chief Medical Officer at Taiho Pharmaceutical Co., Ltd. and later as Chief Medical Officer & Senior Vice President at Taiho Oncology, Inc. He also served as Chief Medical Officer at Apollomics, Inc. (United States).
In terms of education, he received his undergraduate and doctorate degrees from Brown University.
Most recently, he worked as Chief Strategy Officer at ImmunityBio, Inc. in 2021-2022.
Anciens postes connus de Fabio M. Benedetti
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01/05/2022 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Directeur Technique/Scientifique/R&D | 15/09/2006 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Directeur Technique/Scientifique/R&D | 01/01/2005 |
| BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | 01/05/2002 |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops mono therapies and combination therapies of tumor-targeting and immuno-oncology agents | Directeur Technique/Scientifique/R&D | - |
Formation de Fabio M. Benedetti
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taiho Pharmaceutical Co., Ltd.
 Taiho Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops oncology drugs | Commercial Services |
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Health Technology |
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops mono therapies and combination therapies of tumor-targeting and immuno-oncology agents | Health Technology |
ImmunityBio, Inc.
 ImmunityBio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic mechanisms for defeating cancer and infectious disease | Health Technology |
